Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas

Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas

Библиографические подробности
Главные авторы:	Ahmad, M, Catto, J, Azzouzi, A, Cross, S, Feeley, K, Eaton, C, Meuth, M, Hamdy, F, Rehman, I
Формат:	Journal article
Язык:	English
Опубликовано:	2003

Схожие документы

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
по: Rehman, I, и др.
Опубликовано: (2004)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
по: Rehman, I, и др.
Опубликовано: (2004)

Tissue microarray immunohistochemistry and cluster analysis confirms the validity of candidate proteins in prostate cancer identified by proteomic analysis of urine
по: Rehman, I, и др.
Опубликовано: (2005)

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder
по: Yates, DR, и др.
Опубликовано: (2006)

Genetic instability and transitional cell carcinoma of the bladder.
по: Catto, J, и др.
Опубликовано: (2004)

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis
по: Rehman, I, и др.
Опубликовано: (2003)

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
по: Catto, J, и др.
Опубликовано: (2005)

Promoter hypermethylation identifies progression risk in bladder cancer.
по: Yates, DR, и др.
Опубликовано: (2007)

The use of proteomics in urological research
по: Rehman, I, и др.
Опубликовано: (2005)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
по: Yates, DR, и др.
Опубликовано: (2006)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
по: Yates, DR, и др.
Опубликовано: (2005)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
по: van Oers, J, и др.
Опубликовано: (2009)

Clinically localised prostate cancer is microsatellite stable.
по: Azzouzi, A, и др.
Опубликовано: (2007)

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
по: Catto, J, и др.
Опубликовано: (2003)

Loss of intercellular expression of beta-dystroglycan is a common event in prostate cancer and is significantly associated with loss of differentiation
по: Cross, S, и др.
Опубликовано: (2005)

A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis
по: Carolien M. Woolthuis, и др.
Опубликовано: (2013-10-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
по: Rehman, I, и др.
Опубликовано: (2008)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
по: Glen, A, и др.
Опубликовано: (2008)

Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23.
по: Takemura, M, и др.
Опубликовано: (2002)

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
по: Dhawan, D, и др.
Опубликовано: (2006)

Involvement of nucleophosmin (NPM1/B23) in assembly of infectious HPV16 capsids
по: Patricia M. Day, и др.
Опубликовано: (2015-12-01)

Development of a prognostic marker panel in bladder cancer using aberrant promoter methylation
по: Catto, J, и др.
Опубликовано: (2007)

Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder
по: Yates, D, и др.
Опубликовано: (2005)

Urinary Bladder Xanthoma – Is Immunohistochemistry Necessary?
по: M. Raghavendran, и др.
Опубликовано: (2016-09-01)

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
по: Catto, J, и др.
Опубликовано: (2006)

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
по: Catto, J, и др.
Опубликовано: (2003)

Prostate cancer proteomics: The urgent need for clinically validated biomarkers
по: Evans, C, и др.
Опубликовано: (2009)

Gli1 appears to be constitutively expressed in the lumenal epithelial cells of the prostate but not in the basal cell layer or the mesenchyme
по: Spencer, A, и др.
Опубликовано: (2004)

Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.
по: Catto, J, и др.
Опубликовано: (2003)

Nucleophosmin 1 expression in acute myeloid leukemia
по: Mohammad Davoudi, и др.
Опубликовано: (2015-10-01)

Nucleophosmin 1 expression in acute myeloid leukemia
по: Mohammad Davoudi, и др.
Опубликовано: (2015-09-01)

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
по: Rehman, I, и др.
Опубликовано: (2005)

Epigenetic changes in urothelial cancer: A feature of the invasive phenotype and a novel therapeutic target
по: Catto, J, и др.
Опубликовано: (2006)

NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
по: Markéta Šašinková, и др.
Опубликовано: (2021-01-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
по: Roupret, M, и др.
Опубликовано: (2004)

Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation
по: Duangmano Suwit, и др.
Опубликовано: (2012-10-01)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
по: Rouprêt, M, и др.
Опубликовано: (2005)

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
по: Rehman, I, и др.
Опубликовано: (2004)

Targeting chemotherapy to advanced bladder cancer patients most likely to benefit.
по: Catto, J, и др.
Опубликовано: (2010)

Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
по: Grzegorz Sarek, и др.
Опубликовано: (2010-03-01)